Identification of UDP-glucuronosyltransferase isoforms involved in hepatic and intestinal glucuronidation of phytochemical carvacrol

References

• Antonio L, Grillasca JP, Taskinen J, Elovaara E, Burchell B, Piet MH, Ethell B, Ouzzine M, Fournel-Gigleux S, Magdalou J. (2002). Characterization of catechol glucuronidation in rat liver. Drug Metab Dispos 30:199–207.
   PubMed Web of Science ®Google Scholar
• Aristatile B, Al-Numair KS, Veeramani C, Pugalendi KV. (2009). Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats. Fundam Clin Pharmacol 23:757–765.
   PubMed Web of Science ®Google Scholar
• Austgulen LT, Solheim E, Scheline RR. (1987). Metabolism in rats of p-cymene derivatives: carvacrol and thymol. Pharmacol Toxicol 61:98–102.
   PubMedGoogle Scholar
• Baser KH. (2008). Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 14:3106–3119.
   PubMed Web of Science ®Google Scholar
• Court MH. (2005). Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Meth Enzymol 400:104–116.
   PubMed Web of Science ®Google Scholar
• Court MH. (2010). Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 42:209–224.
   PubMed Web of Science ®Google Scholar
• De Vincenzi M, Stammati A, De Vincenzi A, Silano M. (2004). Constituents of aromatic plants: carvacrol. Fitoterapia 75:801–804.
   PubMed Web of Science ®Google Scholar
• Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L. (2010). Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69:193–199.
   PubMed Web of Science ®Google Scholar
• Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L. (2011). Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb–drug interactions. Phytother Res 25:256–263.
   PubMed Web of Science ®Google Scholar
• Green MD, Tephly TR. (1996). Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos 24:356–363.
   PubMed Web of Science ®Google Scholar
• Huang T, Fang ZZ, Zhang YY, Zhu LL, Feng LL, Zheng W, Cao YF, Sun DX, Yang L. (2011). Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver. Pharmazie 66:212–215.
   Google Scholar
• Jamroz D, Wertelecki T, Houszka M, Kamel C. (2006). Influence of diet type on the inclusion of plant origin active substances on morphological and histochemical characteristics of the stomach and jejunum walls in chicken. J Anim Physiol Anim Nutr (Berl) 90:255–268.
   PubMed Web of Science ®Google Scholar
• Jedlitschky G, Cassidy AJ, Sales M, Pratt N, Burchell B. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340 (Pt 3):837–843.
   PubMedGoogle Scholar
• Kerdpin O, Elliot DJ, Mackenzie PI, Miners JO. (2006). Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9. Drug Metab Dispos 34:1950–1953.
   PubMed Web of Science ®Google Scholar
• King CD, Rios GR, Green MD, Tephly TR. (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1:143–161.
   PubMed Web of Science ®Google Scholar
• Kirimer N, Baser KHC, Tumen G. (1995). Carvacrol-rich plants in Turkey. Chem Nat Compounds 31:37–42.
   Google Scholar
• Krishnaswamy S, Duan SX, Von Moltke LL, Greenblatt DJ, Court MH. (2003). Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Dispos 31:133–139.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy S, Hao Q, Von Moltke LL, Greenblatt DJ, Court MH. (2004). Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6. Drug Metab Dispos 32:862–869.
   PubMed Web of Science ®Google Scholar
• Lagouri V, Bleskas G, Tsimidou M, Kokkini S, Boskou D. (1993). Composition and antioxidant activity of essential oils from Oregano plants grown wild in Greece. Z Lebens Unter Fors 197:20–23.
   Google Scholar
• Landa P, Kokoska L, Pribylova M, Vanek T, Marsik P. (2009). In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on COX-2 catalyzed prostaglandin E(2) biosynthesis. Arch Pharm Res 32:75–78.
   PubMed Web of Science ®Google Scholar
• Liang SC, Ge GB, Liu HX, Zhang YY, Wang LM, Zhang JW, Yin L, Li W, Fang ZZ, Wu JJ, Li GH, Yang L. (2010). Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin. Drug Metab Dispos 38:973–980.
   PubMed Web of Science ®Google Scholar
• Liolios CC, Gortzi O, Lalas S, Tsaknis J, Chinou I. (2009). Liposomal incorporation of carvacrol and thymol isolated from the essential oil of Origanum dictamnus L. and in vitro antimicrobial activity. Food Chem 112:77–83.
   Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW. (1997). The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255–269.
   PubMedGoogle Scholar
• Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–685.
   PubMed Web of Science ®Google Scholar
• Menniti AM, Gregori R, Neri F. (2010). Activity of natural compounds on Fusarium verticillioides and fumonisin production in stored maize kernels. Int J Food Microbiol 136:304–309.
   PubMed Web of Science ®Google Scholar
• Miners JO, Knights KM, Houston JB, Mackenzie PI. (2006). In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises. Biochem Pharmacol 71:1531–1539.
   PubMed Web of Science ®Google Scholar
• Miners JO, Mackenzie PI, Knights KM. (2010). The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev 42:196–208.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T. (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461–1464.
   PubMed Web of Science ®Google Scholar
• Palaniappan K, Holley RA. (2010). Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria. Int J Food Microbiol 140:164–168.
   PubMed Web of Science ®Google Scholar
• Qu YQ, Fang ZZ, Yang L, Gao ZM, Liang R, Zhu LL, Dong PP, Zhang YY, Ge GB, Wang LM. (2011). Reversible inhibition of four important human liver cytochrome P450 enzymes by diethylstilbestrol. Pharmazie 66:216–221.
   PubMedGoogle Scholar
• Senafi SB, Clarke DJ, Burchell B. (1994). Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303 (Pt 1):233–240.
   Google Scholar
• Smith PA, Sorich MJ, McKinnon RA, Miners JO. (2003). Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity. J Med Chem 46:1617–1626.
   PubMed Web of Science ®Google Scholar
• Sökmen M, Serkedjieva J, Daferera D, Gulluce M, Polissiou M, Tepe B, Akpulat HA, Sahin F, Sokmen A. (2004). In vitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of Origanum acutidens. J Agric Food Chem 52:3309–3312.
   PubMed Web of Science ®Google Scholar
• Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J. (2010). Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 24:1213–1216.
   PubMed Web of Science ®Google Scholar
• Turgeon D, Carrier JS, Chouinard S, Bélanger A. (2003). Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos 31:670–676.
   PubMed Web of Science ®Google Scholar
• Yanishlieva NV, Marinova EM, Gordon MH, Reneva VG. (1999). Antioxidant activity and mechanism of action of thymol and carvacrol in two lipid systems. Food Chem 64:59–66.
   Web of Science ®Google Scholar
• Zhu L, Ge G, Zhang H, Liu H, He G, Liang S, Zhang Y, Fang Z, Dong P, Finel M, Yang L. (2012). Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms. Drug Metab Dispos 40:529–538.
   PubMed Web of Science ®Google Scholar